SPIKEVAX XBB.1.5
Google image searchProduct monograph
Active ingredient
andusomeran, 0.1 MG/ML
DIN: 02541270
Dosage form(s): DISPERSION
Route(s) of administration: INTRAMUSCULAR
Description: 2.5 ML MULTIDOSE VIAL
Schedule: Schedule D
Company: MODERNA BIOPHARMA CANADA CORPORATION
Date: 18-SEP-2023
ATC:
- J07 — VACCINES (ATC, ATC/DDD, )
- J07B — VIRAL VACCINES (ATC, ATC/DDD)
- J07BN — Covid-19 vaccines (ATC, ATC/DDD)
- J07BN01 — COVID-19, RNA-BASED VACCINE (ATC/DDD)
